glp 1/gip agonist GIP Receptor Agonism Attenuates GLP-1 Receptor Induced Nausea and Emesis in Preclinical Models — Hayes Lab Psychological and behavioral effects of

While the clinical evaluation of GLP-1MK-801 for weight loss awaits, efforts to broaden the scope of developing peptide-mediated targeting of ion channels are encouraged and should not be restricted to metabolic diseases

Next-generation therapies, which include combinations of GLP-1 drugs and other peptides, are being studied for their potential to better preserve muscle and bone compared with GLP-1 drugs alone

9 CaturanoA.DangeloM.MormoneA.RussoV.MollicaM

doi: 10.1002/dmrr.1080 134 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al

Munoz-Mantilla D

DEXA was originally developed to measure bone density, but it also became the gold standard for body composition analysis